SCHEMBL370522

SCHEMBL370522

Cn1cc(C(=O)/C=C/c2cc(Cl)ccc2Cl)ccc1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN5 P54829 1/20 0.43
MAPT P10636 8/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
MAPK1 P28482 1/20 0.41
HSP90AA1 P07900 1/20 0.41
LMNA P02545 4/20 0.41
KDM4E B2RXH2 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
HPGD P15428 2/20 0.41
ATM Q13315 2/20 0.41
ABCG2 Q9UNQ0 1/20 0.41
ALDH1A1 P00352 1/20 0.41
PKM P14618 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAOB P27338 3/20 0.40
NPC1 O15118 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL370523 1.00 PTPN5 (0.43) PTPN5MAPTMEN1KMT2AMAPK1
SCHEMBL370527 0.86 CYP1A1 (0.43) PTPN5MAPTMEN1KMT2AMAPK1
SCHEMBL1390312 0.86 CYP1A1 (0.43) PTPN5MAPTMEN1KMT2AMAPK1
SCHEMBL369121 0.85 CYP1A1 (0.43) PTPN5MAPTMAPK1LMNAKDM4E
SCHEMBL369120 0.85 CYP1A1 (0.43) PTPN5MAPTMAPK1LMNAKDM4E
SCHEMBL363722 0.75 DPP4 (0.55) MAPTMEN1KMT2AMAPK1HSP90AA1
SCHEMBL9338441 0.75 MAPT (0.52) MAPTMEN1KMT2AMAPK1HSP90AA1
SCHEMBL9338458 0.75 MAPT (0.52) MAPTMEN1KMT2AMAPK1HSP90AA1
SCHEMBL370065 0.74 EPHX2 (0.50) PTPN5MAPTMEN1KMT2AMAPK1
SCHEMBL370064 0.74 EPHX2 (0.50) PTPN5MAPTMEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 PTPN5 2385/4885MAPT 4149/4885MEN1 1315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.